Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) FCF Margin (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed FCF Margin for 2 consecutive years, with 25.74% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin rose 8185.0% to 25.74% in Q4 2025 year-over-year; TTM through Dec 2025 was 65.59%, a 438.0% decrease, with the full-year FY2025 number at 65.59%, down 438.0% from a year prior.
  • FCF Margin was 25.74% for Q4 2025 at Day One Biopharmaceuticals, down from 14.59% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 111.99% in Q3 2024 to a low of 1271.11% in Q2 2024.